DOSE OF REALITY: BIG PHARMA’S PATENT THICKETS COST PATIENTS AND TAXPAYERS BILLIONS IN LOST SAVINGS EACH YEAR

New Matrix Global Advisors Report Shines Light on Cost of Big Pharma’s Patent Abuse A new report released on Thursday by Matrix Global Advisors and commissioned by the Coalition for Affordable

01-26-2023 Read More

CSRXP POLL: VOTERS OVERWHELMINGLY SUPPORT HOLDING BIG PHARMA ACCOUNTABLE TO BUILD ON POSITIVE PROGRESS TOWARD LOWERING RX PRICES

Broad Majorities Reject Big Pharma’s Blame Game and Want Policymakers to Advance Market-Based Solutions to Crack Down on Big Pharma’s Egregious Pricing and Anti-Competitive Practices For

01-24-2023 Read More

CSRXP: BIG PHARMA DOUBLES DOWN ON BUSINESS-AS-USUAL AS JANUARY PRICE HIKES CLIMB TO 587

Brand Name Drug Companies Increase Prices on Treatments for Serious Conditions Like Cancers, Autoimmune Conditions, Seizures and More For Immediate Release Contact: Jon Conradi 860-235-3884

01-19-2023 Read More

CSRXP: MODERNA’S 500 PERCENT VACCINE PRICE HIKE A BRAZEN DEMONSTRATION OF BIG PHARMA’S GREED

Brand Name Drug Companies Continue Seeking to Price-Gouge COVID-19 Treatments and Vaccines Ahead of Transition to Commercial Market For Immediate Release Contact: Jon Conradi 860-235-3884

01-9-2023 Read More

ICYMI: STUDY FINDS MEDICARE PART B WOULD HAVE SAVED $3.7 BILLION OVER THREE YEARS IF BIG PHARMA’S PRICE HIKES WERE BELOW THE RATE OF INFLATION

Analysis Finds Drug Companies Increased Prices Faster Than the Rate of Inflation on 70 of the 93 Best-Selling Part B Prescription Drugs In case you missed it

01-9-2023 Read More

BIG PHARMA WATCH: BIG PHARMA SET RECORD FOR OUT-OF-CONTROL LAUNCH PRICES IN 2022 AS MEDIAN PRICE OF NEW TREATMENTS SURGED PAST $220,000

Brand Name Drug Companies Setting Egregious Prices on New Products Not Justified by Clinical Value for Patients In case you missed it, Reuters released a new analysis that found the median annual

01-6-2023 Read More

BIG PHARMA WATCH: U.S. HOUSE REPORT DETAILS “UNJUSTIFIABLY HIGH PRICE” OF UNPROVEN ALZHEIMER’S DRUG ADUHELM

Congressional Probe Concludes Biogen Set Egregious Price Tag on Aduhelm to Maximize Profits, Knew Price Tag Could Lead to Affordability Issues for Patients In case you missed it

01-3-2023 Read More

CSRXP: BIG PHARMA WELCOMES NEW YEAR BY HIKING PRICES ON HUNDREDS OF PRESCRIPTION DRUGS

Brand Name Drug Companies Maintain Business-as-Usual Approach to Price-Gouging the American People at the Start of 2023 For Immediate ReleaseContact: Jon [email protected]

01-3-2023 Read More

DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2022

Get the Facts on Big Pharma’s Year of Out-of-Control Launch Prices, Price Hikes, Anti-Competitive Tactics and Massive Spending on a Debunked Blame Game Despite unprecedented scrutiny of Big

12-28-2022 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.